Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306656 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Repletion in Primary Hyperparathyroidism
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT01306656 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 9 participants.
The verdict
NCT01306656, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will look at the effect of 2 treatment regimens that contain vitamin D in a six-month treatment trial of patients with PHPT who are vitamin D deficient. Patients will be assigned randomly to one of 2 regimens, and will be followed with tests of their blood, urine and bones. This study should provide important information on the effect of vitamin D therapy in patients with PHPT. In addition, data from this study will guide physicians as to how best to treat their patients who have PHPT and vitamin D deficiency.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D
- DRUG 10,000 IU Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-10 |
| Est. Completion | 2017-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01306656
The ClinicalTrials.gov registry entry for NCT01306656 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01306656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01306656 about?
NCT01306656 is a clinical study titled "Vitamin D Repletion in Primary Hyperparathyroidism". This study will look at the effect of 2 treatment regimens that contain vitamin D in a six-month treatment trial of patients with PHPT who are vitamin D deficient. Patients will be assigned randomly to one of 2 regimens, and will be followed with tests of their blood, urine and bones. This study sho...
What is the current status of trial NCT01306656?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2011-10. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01306656?
The interventions under investigation include: Placebo (OTHER), Vitamin D (DIETARY_SUPPLEMENT), 10,000 IU Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01306656?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.